收藏切换
Analysis of the application of the clinical trial Data Monitoring Committee in the research and development of new oncology drugs in China
收藏切换
Yu ZHENG1, Pengbo LI1, Jun LIU1, Zhong WANG1, Haixia DANG2, *, Ya'nan YU1, *
World Clinical Drug | 2025, 46(4) : 315 - 322
Less
收藏切换
World Clinical Drug | 2025, 46(4): 315-322
• Topic •
Analysis of the application of the clinical trial Data Monitoring Committee in the research and development of new oncology drugs in China
Full
Yu ZHENG1, Pengbo LI1, Jun LIU1, Zhong WANG1, Haixia DANG2, *, Ya'nan YU1, *
Affiliations
  • 1.Institute of Clinical Basic Medicine of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
  • 2.Research Center for the Development of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
Published: 2025-04-10 doi: 10.13683/j.wph.2025.04.001
Outline
收藏切换
Objective

To analyze the application status, development trend and existing problems of the Data Monitoring Committee (DMC) in the research and development of new anti-tumor drugs.

Methods

Clinical trials of anti-tumor drugs that were registered and met the conditions in the drug clinical trial registration and information disclosure platform from January 1, 2013 to April 24, 2024 were collected. Descriptive analysis methods were used to analyze the application of DMC in different trial characteristics (trial status, research center, research scope, and research stage, etc.).

Result

A total of 5 320 valid trials were included. Among them, there were 1 018 trials (19.14%) that adopted DMC. The proportion of trials with DMC was relatively high in those that were actively suspended (28.04%) and actively terminated (22.05%). Among the types of drugs, the application rates of DMC in biological products (22.43%) and chemical drugs (16.39%) were higher than those in traditional Chinese medicine (8.16%). The application rate of DMC was higher in phase Ⅲ trials (56.46%) and multi-center trials (22.32%). In terms of indication sites, the application rate of DMC in clinical trials of new anti-tumor drugs for lung and mediastinum (31.41%) and urinary system (37.84%) was relatively high.

Conclusion

The application of DMC in clinical trials of new anti-tumor drugs in China is generally relatively low, but it is slightly higher in high-risk trials. It is recommended to enhance the awareness of the sponsors of setting DMC according to the characteristics of different clinical trials, form more perfect DMC guidelines, and give full play to the advantages of DMC in protecting clinical trials.

clinical trials  /  Data Monitoring Committee  /  oncology  /  new drug development
郑宇, 李鹏博, 刘骏, 王忠, 党海霞, 于亚南. 临床试验数据监查委员会在我国肿瘤新药研发中的应用分析. 世界临床药物, 2025 , 46 (4) : 315 -322 . DOI: 10.13683/j.wph.2025.04.001
Yu ZHENG, Pengbo LI, Jun LIU, Zhong WANG, Haixia DANG, Ya'nan YU. Analysis of the application of the clinical trial Data Monitoring Committee in the research and development of new oncology drugs in China[J]. World Clinical Drug, 2025 , 46 (4) : 315 -322 . DOI: 10.13683/j.wph.2025.04.001
Year 2025 volume 46 Issue 4
44
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.04.001
  • Receive Date:2024-11-20
  • Online Date:2026-11-09
  • Published:2025-04-10
Article Data
Affiliations
History
  • Received:2024-11-20
Funding
Affiliations
    1.Institute of Clinical Basic Medicine of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
    2.Research Center for the Development of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT